Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT
- PMID: 20660388
- DOI: 10.2967/jnumed.110.074773
Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT
Abstract
Simultaneous PET and MRI using new hybrid PET/MRI systems promises optimal spatial and temporal coregistration of structural, functional, and molecular image data. In a pilot study of 10 patients with intracranial masses, the feasibility of tumor assessment using a PET/MRI system comprising lutetium oxyorthosilicate scintillators coupled to avalanche photodiodes was evaluated, and quantification accuracy was compared with conventional PET/CT datasets.
Methods: All measurements were performed with a hybrid PET/MRI scanner consisting of a conventional 3-T MRI scanner in combination with an inserted MRI-compatible PET system. Attenuation correction of PET/MR images was computed from MRI datasets. Diagnoses at the time of referral were low-grade astrocytoma (n = 2), suspicion of low-grade astrocytoma (n = 1), anaplastic astrocytoma (World Health Organization grade III; n = 1), glioblastoma (n = 2), atypical neurocytoma (n = 1), and meningioma (n = 3). In the glial tumors, (11)C-methionine was used for PET; in the meningiomas, (68)Ga-DOTATOC was administered. Tumor-to-gray matter and tumor-to-white matter ratios were calculated for gliomas, and tracer uptake of meningiomas was referenced to nasal mucosa. PET/MRI was performed directly after clinically indicated PET/CT examination.
Results: In all patients, the PET datasets showed similar diagnostic image quality on the hybrid PET/MRI and the PET/CT studies; however, slight streak artifacts were visible in coronal and sagittal sections when using the higher intrinsic resolution of the PET/MRI insert. Prefiltering of images with a 4-mm gaussian filter at a resolution comparable to that of the PET/CT system virtually eliminated these artifacts. Although acquisition of the PET/MR images started at 30-60 min after PET/CT (20.4-min half-life of (11)C) acquisition, the signal-to-noise ratio was good enough, thus underlining the high sensitivity of the PET insert, compared with whole-body PET systems. The computed tumor-to-reference tissue ratios exhibited an excellent accordance between the PET/MRI and PET/CT systems, with a Pearson correlation coefficient of 0.98. Mean paired relative error was 7.9% +/- 12.2%. No significant artifacts or distortions were detected in the simultaneously acquired MR images using the PET/MRI scanner.
Conclusion: Structural, functional, and molecular imaging in patients with brain tumors is feasible with diagnostic imaging quality using simultaneous hybrid PET/MR image acquisition.
Similar articles
-
Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.Invest Radiol. 2013 May;48(5):263-72. doi: 10.1097/RLI.0b013e31828234d0. Invest Radiol. 2013. PMID: 23385399
-
Integrated whole-body PET/MR hybrid imaging: clinical experience.Invest Radiol. 2013 May;48(5):280-9. doi: 10.1097/RLI.0b013e3182845a08. Invest Radiol. 2013. PMID: 23442775
-
PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.J Nucl Med. 2001 Jul;42(7):1053-6. J Nucl Med. 2001. PMID: 11438627
-
Positron emission tomography imaging of brain tumors.Neuroimaging Clin N Am. 2002 Nov;12(4):615-26. doi: 10.1016/s1052-5149(02)00033-3. Neuroimaging Clin N Am. 2002. PMID: 12687915 Review.
-
Future image acquisition trends for PET/MRI.Semin Nucl Med. 2015 May;45(3):201-11. doi: 10.1053/j.semnuclmed.2014.12.002. Semin Nucl Med. 2015. PMID: 25841275 Review.
Cited by
-
Recent advances in mitochondria-targeting theranostic agents.Exploration (Beijing). 2024 Mar 5;4(4):20230063. doi: 10.1002/EXP.20230063. eCollection 2024 Aug. Exploration (Beijing). 2024. PMID: 39175881 Free PMC article. Review.
-
Cyclotron production of manganese-52: a promising avenue for multimodal PET/MRI imaging.EJNMMI Radiopharm Chem. 2024 Aug 2;9(1):57. doi: 10.1186/s41181-024-00288-6. EJNMMI Radiopharm Chem. 2024. PMID: 39093479 Free PMC article.
-
Combining amino acid PET and MRI imaging increases accuracy to define malignant areas in adult glioma.Nat Commun. 2023 Jul 29;14(1):4572. doi: 10.1038/s41467-023-39731-8. Nat Commun. 2023. PMID: 37516762 Free PMC article.
-
Deep learning-enabled quantification of simultaneous PET/MRI for cell transplantation monitoring.iScience. 2023 Jun 9;26(7):107083. doi: 10.1016/j.isci.2023.107083. eCollection 2023 Jul 21. iScience. 2023. PMID: 37416468 Free PMC article.
-
The Role of [68Ga]Ga-DOTA-SSTR PET Radiotracers in Brain Tumors: A Systematic Review of the Literature and Ongoing Clinical Trials.Cancers (Basel). 2022 Jun 14;14(12):2925. doi: 10.3390/cancers14122925. Cancers (Basel). 2022. PMID: 35740591 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical